Endoscopic bariatric therapies

Barham K. Abu Dayyeh, Steven A. Edmundowicz, Sreenivasa Jonnalagadda, Nitin Kumar, Michael Larsen, Shelby Sullivan, Christopher C. Thompson, Subhas Banerjee

Research output: Contribution to journalArticle

71 Scopus citations

Abstract

EBTs hold the promise of providing the next major breakthrough in the management of obesity. At a time when less than 1% of qualified patients actually undergo bariatric surgery, the development of a variety of new endoscopic therapies that replicate the physiological benefits of bariatric surgery in a safe, cost-effective, and minimally invasive fashion may potentially offer the best path to making a meaningful impact on the obesity epidemic. Currently investigated devices have established promising outcomes in short-term weight loss and in control of the metabolic and other medical adverse events of obesity. Pending regulatory approval in the United States, further studies will help define their optimal role in the comprehensive management of obesity.

Original languageEnglish (US)
Pages (from-to)1073-1086
Number of pages14
JournalGastrointestinal Endoscopy
Volume81
Issue number5
DOIs
StatePublished - May 1 2015
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Gastroenterology
  • Radiology Nuclear Medicine and imaging

Cite this

Abu Dayyeh, B. K., Edmundowicz, S. A., Jonnalagadda, S., Kumar, N., Larsen, M., Sullivan, S., Thompson, C. C., & Banerjee, S. (2015). Endoscopic bariatric therapies. Gastrointestinal Endoscopy, 81(5), 1073-1086. https://doi.org/10.1016/j.gie.2015.02.023